Correlation Between Salesforce and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Emergent Biosolutions, you can compare the effects of market volatilities on Salesforce and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Emergent Biosolutions.

Diversification Opportunities for Salesforce and Emergent Biosolutions

0.97
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Salesforce and Emergent is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Salesforce i.e., Salesforce and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between Salesforce and Emergent Biosolutions

Considering the 90-day investment horizon Salesforce is expected to generate 6.47 times less return on investment than Emergent Biosolutions. But when comparing it to its historical volatility, Salesforce is 4.12 times less risky than Emergent Biosolutions. It trades about 0.03 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  328.00  in Emergent Biosolutions on January 23, 2025 and sell it today you would earn a total of  143.00  from holding Emergent Biosolutions or generate 43.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy98.46%
ValuesDaily Returns

Salesforce  vs.  Emergent Biosolutions

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Emergent Biosolutions 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Salesforce and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Emergent Biosolutions

The main advantage of trading using opposite Salesforce and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind Salesforce and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios